Core Points - Atrium Mortgage Investment Corporation has declared a monthly dividend of $0.0775 per common share for November 2025, payable on December 11, 2025, to shareholders of record on November 28, 2025 [1] - The company currently pays monthly dividends at an annual rate of $0.93 per share, with a potential special dividend at year-end if declared dividends are less than taxable income for the fiscal year [2] - Atrium offers a Dividend Reinvestment Plan (DRIP) allowing shareholders to reinvest dividends in new shares at a 2% discount to market price, promoting investment growth over time [3] - Financial results for the quarter ended September 30, 2025, will be released on November 12, 2025, followed by a conference call on November 13, 2025, at 4:00 p.m. ET to discuss the results [4] - Atrium is a non-bank lender specializing in residential and commercial mortgages in major urban centers in Canada, focusing on delivering stable dividends while maintaining conservative lending practices [5] - As a Mortgage Investment Corporation (MIC) under the Canada Income Tax Act, Atrium is not subject to corporate income tax if taxable income is distributed as dividends within 90 days after year-end [6]

Core Insights - C3.ai's agentic AI initiative is becoming a significant growth driver, with the introduction of the C3 Agentic AI Platform and the Strategic Integrator Program aimed at enabling enterprises and government agencies to create domain-specific AI applications [1][10] - The platform addresses key generative AI challenges, ensuring enterprise-grade reliability and achieving a high success rate in large-scale deployments across various sectors [2] - C3.ai has secured early deployments with notable clients like the U.S. Army and Nucor, showcasing its potential in agentic AI adoption [3][10] - The company is targeting a $2 trillion addressable market, with increasing government adoption and OEM partnerships, positioning itself for a leading role in the agentic AI segment [4] Company Developments - The C3 Agentic AI Platform combines generative pretrained transformers with secure workflows, effectively mitigating risks such as data exfiltration and cybersecurity threats [2] - The platform's open architecture prevents vendor lock-in and is supported by 131 pre-built enterprise AI applications, enhancing its competitive differentiation [3] - C3.ai's OEM model allows partners to license and customize its technology, expanding market reach without incurring additional sales costs [10] Competitive Landscape - Competitors like Palantir Technologies and BigBear.ai are emerging as significant challengers in the agentic AI space, with Palantir expanding its AI platform for government and commercial clients [5][6] - BigBear.ai is developing mission-ready agentic AI tools, increasing competition for enterprise-scale AI transformation projects [7] Financial Performance - C3.ai's stock has seen a decline of 31% over the past three months, contrasting with a 3.5% decline in the industry [8] - The company trades at a forward price-to-sales ratio of 7.8X, significantly lower than the industry average of 17.12X, indicating potential undervaluation [12] - Analyst sentiment has become more cautious, with fiscal 2026 EPS estimates widening to a loss of $1.33, reflecting deeper expected losses compared to previous estimates [14]

Core Insights - The artificial intelligence industry is experiencing rapid growth, but companies like BigBear.ai and C3.ai showcase contrasting financial performances and market strategies [1][2] BigBear.ai Overview - BigBear.ai is positioned as a mission-driven AI integrator focusing on defense, logistics, and national security, benefiting from U.S. government funding initiatives like OB3, which allocates $170 billion for Homeland Security and $150 billion for the Department of Defense [2][4] - In Q2 2025, BigBear.ai reported a revenue decline of 18% year-over-year to $32.5 million but improved its cash position to $390.8 million, enhancing its capacity for acquisitions and growth [4][6] - The company has a $380 million backlog and anticipates revenue between $125 million and $140 million for 2025, indicating potential for reacceleration as government funding materializes [6][10] - Despite a net loss of $228.6 million in Q2 due to one-time charges, the improving balance sheet and international expansion plans provide significant growth options [7] C3.ai Overview - C3.ai's fiscal Q1 2026 results revealed a 19% revenue decline to $70.3 million, with a widened non-GAAP net loss of $49.8 million, attributed to sales restructuring and leadership changes [8][10] - Subscription revenue accounted for 86% of total revenue, and the company secured 46 agreements, including partnerships with major industry players [9][11] - C3.ai's gross margin fell to 52% from 65% due to increased deployment costs, and the company withdrew its fiscal 2026 guidance, reflecting management caution [12][22] Valuation and Market Performance - BigBear.ai trades at a forward price-to-sales (P/S) multiple of 17.89X, while C3.ai trades at 7.63X, both above the sector average of 6.94X, indicating differing investor sentiments [13][14] - Year-to-date, BigBear.ai shares have surged 48.5%, while C3.ai has dropped 49%, reflecting contrasting investor confidence and execution challenges [10][15][16] Future Outlook - BigBear.ai is expected to report a loss of $1.10 per share in 2025, with a projected revenue decline of 16.2% in 2025 but a growth of 24.3% in 2026 as new contracts are expected to scale [20] - C3.ai's EPS estimate for fiscal 2026 has widened to a loss of $1.33, with revenues expected to decline sharply before rebounding in fiscal 2027 [22][23] - BigBear.ai's strategic leverage to government spending and its strong cash position suggest more immediate upside potential, while C3.ai may require time to stabilize and recover [25][27]

Core Insights - The individual has extensive experience in risk management and financial analysis, with a strong educational background in applied risk management and relevant certifications [1] - The focus areas include risk management, financial analysis, data science, and the influence of economic factors on financial markets [1] - The motivation for writing is to provide actionable insights for investors by translating complex financial data into understandable analysis [1] Group 1 - The individual holds an MSc in Applied Risk Management from the University of Athens and has completed the ACA Certificate Level [1] - The professional background includes roles in assurance, financial analysis, and trade operations at leading firms such as EY, PwC, Alpha Bank, and the National Bank of Greece [1] - The approach to investing emphasizes data-driven analysis and long-term value creation [1] Group 2 - The individual aims to write on topics related to risk assessment, financial modeling, and stock analysis [1] - There is a commitment to providing informed analysis on market trends, risk management practices, and investment strategies [1]

Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health concerns, which ultimately led to a significant drop in stock price following disappointing financial results [1][4][5]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129, and is pending in the Northern District of California, representing purchasers or acquirers of C3.ai securities [1]. - The lawsuit claims that C3.ai's optimistic reports on growth and profitability were misleading and overly reliant on the health of its CEO [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal year 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, resulting in a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff, representing the interests of the class [6]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and can select a law firm to litigate the lawsuit [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years, indicating its prominence in the field [7].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of C3.ai, Inc. regarding a class action lawsuit due to allegations of misleading statements and concealment of material facts that negatively impacted the company's stock performance [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that C3.ai's management provided overly positive statements while concealing significant issues, particularly the health of the CEO, which affected the company's ability to close deals [1]. - The company failed to execute its profit and growth potential due to these undisclosed challenges [1]. Financial Impact - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026 [1]. - The stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 26, 2025, to August 8, 2025) are encouraged to register for the class action [2]. - The deadline for seeking lead plaintiff status is October 21, 2025, and there is no cost to participate in the case [2].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects, particularly in relation to CEO Thomas M. Siebel's health issues [1][2][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit, titled Liggett v. C3.ai, Inc., claims that C3.ai provided overly optimistic revenue projections while downplaying risks associated with CEO Siebel's health [2]. - The class period for the lawsuit is from February 26, 2025, to August 8, 2025, with a lead plaintiff deadline set for October 21, 2025 [2][4]. Financial Impact - Following C3.ai's financial announcement on August 8, 2025, which revealed preliminary first-quarter results that did not meet expectations and a lowered revenue guidance for the fiscal year, the company's stock price dropped by over 25% [3]. Investigation Focus - The investigation is centered on whether C3.ai's public statements were misleading, particularly regarding the impact of CEO Siebel's health on the company's ability to achieve financial targets [5].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. and its executives for alleged violations of the Securities Exchange Act of 1934, claiming misleading information regarding the company's revenue outlook and CEO's health concerns [1][4]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) and aims to represent purchasers or acquirers of C3.ai securities [1]. - Allegations include that C3.ai's executives created a false impression of reliable revenue projections while downplaying risks associated with CEO Thomas M. Siebel's health [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 FY 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, leading to a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff [6]. - The lead plaintiff is typically the investor with the greatest financial interest and acts on behalf of all class members [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [7].

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of C3.ai, Inc. (NYSE: AI). Shareholders who purchased shares of AI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=172056&from=3 CLASS PERIOD: February 26, 2025 to August ...

Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects [1] Company Summary - The lawsuit targets C3.ai, an enterprise AI software company, and claims violations of the Securities Exchange Act of 1934 [1] - The suit was filed in the U.S. District Court for the Northern District of California [1] - Investors who suffered significant losses are urged to submit their claims [1]